Browsing: Spotlight

Cambridge has a habit of producing companies that sound academic right up until the money starts moving, the science starts…

In 2018, while much of venture capital was still mistaking pattern recognition for prophecy, Arjun Sethi, Jonathan Hsu, and Ted…

Some firms chase trends. 8VC hunts systems. The kind that quietly decide whether hospitals function, freight moves, or a nation…

In gene therapy, most companies obsess over the message. The code. The payload. Affinia Therapeutics was built around a harder…

Some firms raise capital. Others raise standards. Greycroft has been doing the second one quietly, consistently, and with the kind…

Alchemy has always sounded like magic, but this story is pure engineering discipline with a sense of humor sharp enough…

Venrock does not need a press cycle to remind the market it has been here longer than the market itself.…

Animoca Brands never sounded like a startup to me. It sounded like a holding company with a point of view…

Canaan Partners does not feel like a firm chasing momentum. It feels like a firm that remembers where momentum actually…

The RNA wave has moved past theory and into consequence. Capital is flowing, clinical data is maturing, and the market…